EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Breaking the deadlock in antigen discovery for Leishmania vaccines

Wim Adriaensen, Nicky de Vrij, Thao-Thy Pham, Kris Laukens, Pieter Meysman, Paul M Kaye

Trends in Parasitology · 2026-03 · 42 (3) · 183-191

DOI: 10.1016/j.pt.2026.01.005 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Trends in Parasitology, 2026-03. Verfasst von Wim Adriaensen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Immunology Unit, Department of Clinical Sciences, Institute of Tropical Medicine Antwerp, Antwerp 2000, Belgium. Electronic address: wadriae…. Hauptthemen laut MEDLINE: Antigens, Protozoan, Leishmaniasis Vaccines, Leishmania, Leishmaniasis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 62 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite the global burden of leishmaniasis, no licensed human vaccine exists. Vaccine antigens are typically based on in silico predictions or their immunogenicity in animal models and cured patients. T cell epitopes have only been mapped for fewer than 2% of over 8000 Leishmania proteins, with only ten proteins tested in clinical trials. Whether infected human phagocytes naturally present such antigens early on during infection, and prior to the onset of parasite-induced regulatory mechanisms, is unknown. We discuss why this is critical to the induction of protective immunity and argue that antigen availability can conclusively guide and accelerate vaccine candidate discovery. Here, emerging technologies, including immunopeptidomics, single-cell multiomics, and T cell receptor repertoire mapping, offer transformative opportunities to redefine Leishmania antigen discovery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antigens, ProtozoanLeishmaniasis VaccinesLeishmaniaLeishmaniasisVaccine DevelopmentHumansAnimals

Stichwörter der Autor:innen

Leishmaniaantigen discoveryleishmaniasisvaccine

Substanzen

Antigens, ProtozoanLeishmaniasis Vaccines

Autor:innen und Institutionen

  • Clinical Immunology Unit, Department of Clinical Sciences, Institute of Tropical Medicine Antwerp, Antwerp 2000, Belgium. Electronic address: wadriaensen@itg.be.
  • Clinical Immunology Unit, Department of Clinical Sciences, Institute of Tropical Medicine Antwerp, Antwerp 2000, Belgium; ADREM Data Lab, Department of Computer Science, University of Antwerp, Antwerp 2020, Belgium.
  • Clinical Immunology Unit, Department of Clinical Sciences, Institute of Tropical Medicine Antwerp, Antwerp 2000, Belgium.
  • ADREM Data Lab, Department of Computer Science, University of Antwerp, Antwerp 2020, Belgium.
  • York Biomedical Research Institute and Hull York Medical School, University of York, Heslington, UK.

Zitieren

APA

Adriaensen, W., de Vrij, N., Pham, T. T., Laukens, K., Meysman, P., & Kaye, P. M. (2026). Breaking the deadlock in antigen discovery for Leishmania vaccines. Trends in Parasitology, 42(3), 183-191. https://doi.org/10.1016/j.pt.2026.01.005

Vancouver

Adriaensen W, de Vrij N, Pham TT, Laukens K, Meysman P, Kaye PM. Breaking the deadlock in antigen discovery for Leishmania vaccines. Trends in Parasitology. 2026;42(3):183-191. doi:10.1016/j.pt.2026.01.005

BibTeX
@article{Adriaensen2026,
  author = {Adriaensen, Wim and de Vrij, Nicky and Pham, Thao-Thy and Laukens, Kris and Meysman, Pieter and Kaye, Paul M},
  title = {Breaking the deadlock in antigen discovery for Leishmania vaccines},
  journal = {Trends in Parasitology},
  year = {2026},
  volume = {42},
  number = {3},
  pages = {183--191},
  doi = {10.1016/j.pt.2026.01.005}
}
Kostenlos starten →